Perez, E. A., de Haas, S. L., Eiermann, W., Barrios, C. H., Toi, M., Im, Y., . . . Ellis, P. A. (2019). Relationship between tumor biomarkers and efficacy in MARIANNE, a phase III study of trastuzumab emtansine ± pertuzumab versus trastuzumab plus taxane in HER2-positive advanced breast cancer. BMC cancer, 19(1), 517-14. https://doi.org/10.1186/s12885-019-5687-0
Citácia podle Chicago (17th ed.)Perez, Edith A., et al. "Relationship Between Tumor Biomarkers and Efficacy in MARIANNE, a Phase III Study of Trastuzumab Emtansine ± Pertuzumab Versus Trastuzumab Plus Taxane in HER2-positive Advanced Breast Cancer." BMC Cancer 19, no. 1 (2019): 517-14. https://doi.org/10.1186/s12885-019-5687-0.
Citácia podľa MLA (8th ed.)Perez, Edith A., et al. "Relationship Between Tumor Biomarkers and Efficacy in MARIANNE, a Phase III Study of Trastuzumab Emtansine ± Pertuzumab Versus Trastuzumab Plus Taxane in HER2-positive Advanced Breast Cancer." BMC Cancer, vol. 19, no. 1, 2019, pp. 517-14, https://doi.org/10.1186/s12885-019-5687-0.